Anagrelide: A Clinically Effective cAMP Phosphodiesterase 3A Inhibitor with Molecular Glue Properties.
Meanwell NA.
ACS Med Chem Lett · article-commentary; journal article · DOI 10.1021/acsmedchemlett.3c00092 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för imazodan. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
21 träffarChemical genetics reveals a complex functional ground state of neural stem cells.
Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB.
Nat Chem Biol · research support, non-u.s. gov't; journal article · DOI 10.1038/nchembio873Cyclic nucleotide phosphodiesterase inhibition by imidazopyridines: analogues of sulmazole and isomazole as inhibitors of the cGMP specific phosphodiesterase.
Coates WJ, Connolly B, Dhanak D, Flynn ST, Worby A.
J Med Chem · comparative study; journal article · DOI 10.1021/jm00062a0113,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase.
Martinez GR, Walker KA, Hirschfeld DR, Bruno JJ, Yang DS, Maloney PJ.
J Med Chem · journal article · DOI 10.1021/jm00082a0021,4-bis(3-oxo-2,3-dihydropyridazin-6-yl)benzene analogues: potent phosphodiesterase inhibitors and inodilators.
Coates WJ, Prain HD, Reeves ML, Warrington BH.
J Med Chem · journal article · DOI 10.1021/jm00168a0316-Benzoxazinylpyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents.
Combs DW, Rampulla MS, Bell SC, Klaubert DH, Tobia AJ, Falotico R, Haertlein B, Lakas-Weiss C, Moore JB.
J Med Chem · comparative study; journal article · DOI 10.1021/jm00163a061Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure.
Sircar I, Steffen RP, Bobowski G, Burke SE, Newton RS, Weishaar RE, Bristol JA, Evans DB.
J Med Chem · journal article · DOI 10.1021/jm00122a011Chemistry and positive inotropic effect of pelrinone and related derivatives. A novel class of 2-methylpyrimidones as inotropic agents.
Bagli J, Bogri T, Palameta B, Rakhit S, Peseckis S, McQuillan J, Lee DK.
J Med Chem · journal article · DOI 10.1021/jm00399a023Imidazole-pyridine bioisosterism: comparison of the inotropic activities of pyridine- and imidazole-substituted 6-phenyldihydropyridazinone cardiotonics.
Robertson DW, Krushinski JH, Pollock GD, Hayes JS.
J Med Chem · comparative study; journal article · DOI 10.1021/jm00397a033Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correlation with in vivo positive inotropic activity.
Sircar I, Weishaar RE, Kobylarz D, Moos WH, Bristol JA.
J Med Chem · journal article · DOI 10.1021/jm00394a005Cardiotonic agents. 8. Selective inhibitors of adenosine 3',5'-cyclic phosphate phosphodiesterase III. Elaboration of a five-point model for positive inotropic activity.
Moos WH, Humblet CC, Sircar I, Rithner C, Weishaar RE, Bristol JA, McPhail AT.
J Med Chem · journal article · DOI 10.1021/jm00394a006Cardiotonic agents. 6. Synthesis and inotropic activity of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones: ring-contracted analogues of imazodan (CI-914).
Sircar I, Morrison GC, Burke SE, Skeean R, Weishaar RE.
J Med Chem · journal article · DOI 10.1021/jm00393a007Cardiotonic agents. 2. (Imidazolyl)aroylimidazolones, highly potent and selective positive inotropic agents.
Hagedorn AA, Erhardt PW, Lumma WC, Wohl RA, Cantor E, Chou YL, Ingebretsen WR, Lampe JW, Pang D, Pease CA.
J Med Chem · comparative study; journal article · DOI 10.1021/jm00391a013A novel class of cardiotonics. Synthesis and pharmacological properties of [4-(substituted-amino)phenyl]pyridazinones and related derivatives.
Okushima H, Narimatsu A, Kobayashi M, Furuya R, Tsuda K, Kitada Y.
J Med Chem · journal article · DOI 10.1021/jm00390a007Dihydropyridazinone cardiotonics: synthesis and inotropic activity of 5'-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)spiro[cycloalkane- 1,3'-[3H]indol]-2'(1'H)-ones.
Robertson DW, Krushinski JH, Pollock GD, Wilson H, Kauffman RF, Hayes JS.
J Med Chem · comparative study; journal article · DOI 10.1021/jm00388a014In search of the digitalis replacement.
Erhardt PW.
J Med Chem · review; journal article · DOI 10.1021/jm00385a001Dihydropyridazinone cardiotonics: the discovery and inotropic activity of 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H -indol-2- one.
Robertson DW, Krushinski JH, Beedle EE, Wyss V, Pollock GD, Wilson H, Kauffman RF, Hayes JS.
J Med Chem · journal article · DOI 10.1021/jm00160a006Cardiotonic agents. 3. Synthesis and biological activity of novel 6-(substituted 1H-imidazol-4(5)-yl)-3(2H)-pyridazinones.
Sircar I, Bobowski G, Bristol JA, Weishaar RE, Evans DB.
J Med Chem · journal article · DOI 10.1021/jm00152a015Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents.
Sircar I, Duell BL, Bobowski G, Bristol JA, Evans DB.
J Med Chem · journal article · DOI 10.1021/jm00148a006A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
Weishaar RE, Cain MH, Bristol JA.
J Med Chem · review; journal article · DOI 10.1021/jm50001a001Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3 (2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure.
Bristol JA, Sircar I, Moos WH, Evans DB, Weishaar RE.
J Med Chem · journal article · DOI 10.1021/jm00375a001